These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 26432994
1. Correlation of diffusion tensor and dynamic susceptibility contrast MRI with DNA ploidy and cell cycle analysis of gliomas. Zikou A, Alexiou GA, Vartholomatos G, Goussia A, Xydis VG, Kosta P, Voulgaris S, Kyritsis AP, Argyropoulou MI. Clin Neurol Neurosurg; 2015 Dec; 139():119-24. PubMed ID: 26432994 [Abstract] [Full Text] [Related]
2. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma. Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Kyritsis AP, Fotopoulos AD, Argyropoulou MI. Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151 [Abstract] [Full Text] [Related]
4. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y. Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [Abstract] [Full Text] [Related]
5. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma. Lin YW, Tai SH, Chang CC, Chao LC, Wen MJ, Huang YH, Hung HY, Lee EJ. Neurol Res; 2016 Jul; 38(7):625-33. PubMed ID: 27264544 [Abstract] [Full Text] [Related]
6. Analysis of diffusion tensor imaging metrics for gliomas grading at 3 T. Server A, Graff BA, Josefsen R, Orheim TE, Schellhorn T, Nordhøy W, Nakstad PH. Eur J Radiol; 2014 Mar; 83(3):e156-65. PubMed ID: 24457139 [Abstract] [Full Text] [Related]
7. The role of diffusion tensor imaging and dynamic susceptibility perfusion MRI in the evaluation of meningioma grade and subtype. Zikou A, Alexiou GA, Goussia A, Kosta P, Xydis V, Voulgaris S, Kyritsis AP, Argyropoulou MI. Clin Neurol Neurosurg; 2016 Jul; 146():109-15. PubMed ID: 27208870 [Abstract] [Full Text] [Related]
8. The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors. Vartholomatos G, Alexiou GA, Stefanaki K, Lykoudis EG, Tseka G, Tzoufi M, Sfakianos G, Prodromou N. Clin Neurol Neurosurg; 2015 Jun; 133():70-4. PubMed ID: 25867234 [Abstract] [Full Text] [Related]
9. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume. Choi YS, Ahn SS, Lee SK, Chang JH, Kang SG, Kim SH, Zhou J. Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517 [Abstract] [Full Text] [Related]
10. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema. De Belder FE, Oot AR, Van Hecke W, Venstermans C, Menovsky T, Van Marck V, Van Goethem J, Van den Hauwe L, Vandekerckhove M, Parizel PM. J Comput Assist Tomogr; 2012 Aug; 36(5):577-82. PubMed ID: 22992609 [Abstract] [Full Text] [Related]
11. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Thomsen H, Steffensen E, Larsson EM. Acta Radiol; 2012 Feb 01; 53(1):95-101. PubMed ID: 22114021 [Abstract] [Full Text] [Related]
12. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. Clin Radiol; 2005 Apr 01; 60(4):493-502. PubMed ID: 15767107 [Abstract] [Full Text] [Related]
13. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics. Ma L, Song ZJ. Clin Neurol Neurosurg; 2013 Dec 01; 115(12):2489-95. PubMed ID: 24183513 [Abstract] [Full Text] [Related]
14. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma. Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos AD, Argyropoulou MI. Magn Reson Imaging; 2014 Sep 01; 32(7):854-9. PubMed ID: 24848292 [Abstract] [Full Text] [Related]
15. DNA content is associated with malignancy of intracranial neoplasms. Alexiou GA, Vartholomatos E, Goussia A, Dova L, Karamoutsios A, Fotakopoulos G, Kyritsis AP, Voulgaris S. Clin Neurol Neurosurg; 2013 Sep 01; 115(9):1784-7. PubMed ID: 23683441 [Abstract] [Full Text] [Related]
16. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma. Smitha KA, Gupta AK, Jayasree RS. Br J Radiol; 2015 Aug 01; 88(1052):20140784. PubMed ID: 26110202 [Abstract] [Full Text] [Related]
17. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method. Cebeci H, Aydin O, Ozturk-Isik E, Gumus C, Inecikli F, Bekar A, Kocaeli H, Hakyemez B. Eur J Radiol; 2014 Oct 01; 83(10):1914-9. PubMed ID: 25087109 [Abstract] [Full Text] [Related]
18. Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma? Hiremath SB, Muraleedharan A, Kumar S, Nagesh C, Kesavadas C, Abraham M, Kapilamoorthy TR, Thomas B. AJNR Am J Neuroradiol; 2017 Apr 01; 38(4):685-690. PubMed ID: 28209583 [Abstract] [Full Text] [Related]
19. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R, Babb J, Law M, Pollack E, Johnson G. J Magn Reson Imaging; 2007 Oct 01; 26(4):1053-63. PubMed ID: 17896374 [Abstract] [Full Text] [Related]
20. Diffusion Tensor Imaging in brain tumors: A study on gliomas and metastases. Papageorgiou TS, Chourmouzi D, Drevelengas A, Kouskouras K, Siountas A. Phys Med; 2015 Nov 01; 31(7):767-73. PubMed ID: 25866320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]